podophyllotoxin has been researched along with Cancer of the Ureter in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
| Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T | 1 |
2 other study(ies) available for podophyllotoxin and Cancer of the Ureter
| Article | Year |
|---|---|
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1988 |
[Effect of etoposide for urogenital tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |